I hate to disagree wit you gestatl2 but IMO, and mine only, we must full fill the 75 patients in the enrollment to satisfy the FDA unfortunately. This way, the FDA can't say, "Cytodyn, you need to finish the trial as stated in the protocol. BUT, if we can submit the first 50 and the FDA realizes that we are still going to finish through the 75, then IMO, that's okay and we won't be known for not finishing according to the designed protocol.

What are your thoughts on that? When the results of the first 50 are revealed and they are just that, spectacular, we get the exposure through the media and CYDY is still going to finish the results with out asking for approval of just 50, they'll know we are going to complete the trial.

Wow, FDA, give Leronlimab a break, will ya? It FLAT OUR WORKS

GLTU and love your contributions gestatl2, keep em coming

RE:EDITED. gestalt2, I do agree with you, my bad, but let the FDA know for sure we are not asking just for approval on the 50 patients but we are also wanting to finish the 75 as the protocol stated but if you think the results are as spectacular as we think they are, go ahead and approve us on the 50. You, (FDA) could also tell us to stop the trial and approve Leronlimab too

HCIT